DATA INTEGRATION : Universal Data Standards - Are We Almost There Yet? Beyond the Final eFrontier When EDC and EHR Converge Also in this issue : How Washington?s Health Reform Impacts Pharma, Efforts to Reach Consensus on ePRO in the EU, An Intimate Look at the Trial Volunteer Experience, Braving the World of Social Media
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.